A Two-Dimensional ERK-AKT Signaling Code for an NGF-Triggered Cell-Fate Decision

Molecular Cell

Volumn 45, Issue 2, 2012, Pages 196-209

  Chen, Jia Yun ^a   Lin, Jia Ren ^a   Cimprich, Karlene A ^a   Meyer, Tobias ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; NERVE GROWTH FACTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RAS PROTEIN;

ANIMAL CELL; ARTICLE; CELL COUNT; CELL CYCLE; CELL FATE; CELL PROLIFERATION; CELL SUBPOPULATION; NEGATIVE FEEDBACK; NONHUMAN; RAT; SINGLE CELL ANALYSIS;

ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; CYCLIN D; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; MAP KINASE SIGNALING SYSTEM; NERVE GROWTH FACTOR; PC12 CELLS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEIN STABILITY; PROTO-ONCOGENE PROTEINS C-AKT; RAS GTPASE-ACTIVATING PROTEINS; RATS;

EID: 84856264773     PISSN: 10972765     EISSN: 10974164     Source Type: Journal    
DOI: 10.1016/j.molcel.2011.11.023     Document Type: Article

References (38)

1. Acar M., Pando B.F., Arnold F.H., Elowitz M.B., van Oudenaarden A. A general mechanism for network-dosage compensation in gene circuits. Science 2010, 329:1656-1660.
2. Albert R. Scale-free networks in cell biology. J.Cell Sci. 2005, 118:4947-4957.
3. Arias A.M., Hayward P. Filtering transcriptional noise during development: concepts and mechanisms. Nat. Rev. Genet. 2006, 7:34-44.
4. Balázsi G., van Oudenaarden A., Collins J.J. Cellular decision making and biological noise: from microbes to mammals. Cell 2011, 144:910-925.
5. Bar-Sagi D., Feramisco J.R. Microinjection of the ras oncogene protein into PC12 cells induces morphological differentiation. Cell 1985, 42:841-848.
6. Barabási A.L., Oltvai Z.N. Network biology: understanding the cell's functional organization. Nat. Rev. Genet. 2004, 5:101-113.
7. Blake W.J., KAErn M., Cantor C.R., Collins J.J. Noise in eukaryotic gene expression. Nature 2003, 422:633-637.
8. Blake W.J., Balázsi G., Kohanski M.A., Isaacs F.J., Murphy K.F., Kuang Y., Cantor C.R., Walt D.R., Collins J.J. Phenotypic consequences of promoter-mediated transcriptional noise. Mol. Cell 2006, 24:853-865.
9. Campbell S.L., Khosravi-Far R., Rossman K.L., Clark G.J., Der C.J. Increasing complexity of Ras signaling. Oncogene 1998, 17(11 Reviews):1395-1413.
10. Carracedo A., Pandolfi P.P. The PTEN-PI3K pathway: of feedbacks and cross-talks. Oncogene 2008, 27:5527-5541.
11. Chambard J.C., Lefloch R., Pouysségur J., Lenormand P. ERK implication in cell cycle regulation. Biochim. Biophys. Acta 2007, 1773:1299-1310.
12. Chiu V.K., Bivona T., Hach A., Sajous J.B., Silletti J., Wiener H., Johnson R.L., Cox A.D., Philips M.R. Ras signalling on the endoplasmic reticulum and the Golgi. Nat. Cell Biol. 2002, 4:343-350.
13. Colman-Lerner A., Gordon A., Serra E., Chin T., Resnekov O., Endy D., Pesce C.G., Brent R. Regulated cell-to-cell variation in a cell-fate decision system. Nature 2005, 437:699-706.
14. Crespo P., León J. Ras proteins in the control of the cell cycle and cell differentiation. Cell. Mol. Life Sci. 2000, 57:1613-1636.
15. Deppmann C.D., Mihalas S., Sharma N., Lonze B.E., Niebur E., Ginty D.D. A model for neuronal competition during development. Science 2008, 320:369-373.
16. Diehl J.A., Cheng M., Roussel M.F., Sherr C.J. Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev. 1998, 12:3499-3511.
17. Dijkmans T.F., van Hooijdonk L.W., Schouten T.G., Kamphorst J.T., Vellinga A.C., Meerman J.H., Fitzsimons C.P., de Kloet E.R., Vreugdenhil E. Temporal and functional dynamics of the transcriptome during nerve growth factor-induced differentiation. J.Neurochem. 2008, 105:2388-2403.
18. Friedman A., Perrimon N. Genetic screening for signal transduction in the era of network biology. Cell 2007, 128:225-231.
19. Greene L.A., Tischler A.S. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc. Natl. Acad. Sci. USA 1976, 73:2424-2428.
20. Huang E.J., Reichardt L.F. Trk receptors: roles in neuronal signal transduction. Annu. Rev. Biochem. 2003, 72:609-642.
21. Katso R., Okkenhaug K., Ahmadi K., White S., Timms J., Waterfield M.D. Cellular function of phosphoinositide 3-kinases: implications for development, homeostasis, and cancer. Annu. Rev. Cell Dev. Biol. 2001, 17:615-675.
22. Lemmon M.A., Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell 2010, 141:1117-1134.
23. Lockyer P.J., Wennström S., Kupzig S., Venkateswarlu K., Downward J., Cullen P.J. Identification of the ras GTPase-activating protein GAP1(m) as a phosphatidylinositol-3,4,5-trisphosphate-binding protein invivo. Curr. Biol. 1999, 9:265-268.
24. Maekawa M., Li S., Iwamatsu A., Morishita T., Yokota K., Imai Y., Kohsaka S., Nakamura S., Hattori S. A novel mammalian Ras GTPase-activating protein which has phospholipid-binding and Btk homology regions. Mol. Cell. Biol. 1994, 14:6879-6885.
25. Manning B.D., Cantley L.C. AKT/PKB signaling: navigating downstream. Cell 2007, 129:1261-1274.
26. Marshall C.J. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 1995, 80:179-185.
27. Morgan D.O. The Cell Cycle: Principles of Control 2007, Sinauer Associates, Sunderland, MA.
28. Myers J.W., Jones J.T., Meyer T., Ferrell J.E. Recombinant Dicer efficiently converts large dsRNAs into siRNAs suitable for gene silencing. Nat. Biotechnol. 2003, 21:324-328.
29. Niepel M., Spencer S.L., Sorger P.K. Non-genetic cell-to-cell variability and the consequences for pharmacology. Curr. Opin. Chem. Biol. 2009, 13:556-561.
30. Okkenhaug K., Vanhaesebroeck B. PI3K in lymphocyte development, differentiation and activation. Nat. Rev. Immunol. 2003, 3:317-330.
31. Salmeen A., Park B.O., Meyer T. The NADPH oxidases NOX4 and DUOX2 regulate cell cycle entry via a p53-dependent pathway. Oncogene 2010, 29:4473-4484.
32. Santos S.D., Verveer P.J., Bastiaens P.I. Growth factor-induced MAPK network topology shapes Erk response determining PC-12 cell fate. Nat. Cell Biol. 2007, 9:324-330.
33. Sasagawa S., Ozaki Y., Fujita K., Kuroda S. Prediction and validation of the distinct dynamics of transient and sustained ERK activation. Nat. Cell Biol. 2005, 7:365-373.
34. Shao J., Sheng H., DuBois R.N., Beauchamp R.D. Oncogenic Ras-mediated cell growth arrest and apoptosis are associated with increased ubiquitin-dependent cyclin D1 degradation. J.Biol. Chem. 2000, 275:22916-22924.
35. Sherr C.J., Roberts J.M. Living with or without cyclins and cyclin-dependent kinases. Genes Dev. 2004, 18:2699-2711.
36. Spencer S.L., Gaudet S., Albeck J.G., Burke J.M., Sorger P.K. Non-genetic origins of cell-to-cell variability in TRAIL-induced apoptosis. Nature 2009, 459:428-432.
37. von Kriegsheim A., Baiocchi D., Birtwistle M., Sumpton D., Bienvenut W., Morrice N., Yamada K., Lamond A., Kalna G., Orton R., et al. Cell fate decisions are specified by the dynamic ERK interactome. Nat. Cell Biol. 2009, 11:1458-1464.
38. Zhou J., Valletta J.S., Grimes M.L., Mobley W.C. Multiple levels for regulation of TrkA in PC12 cells by nerve growth factor. J.Neurochem. 1995, 65:1146-1156.